Malaria Vaccine
Why it Matters?
The Union government licensed five firms to manufacture India’s first indigenous malaria vaccine (AdFalciVax), developed by ICMR and partners.
What You Should Know?
The vaccine is a recombinant chimeric multi-stage vaccine developed to fight malaria.
It specifically targets Plasmodium falciparum, the deadliest malaria parasite.
It works by preventing the parasite from entering the bloodstream, which reduces both infection in individuals and transmission within communities.
It is designed to be affordable and scalable, making it suitable for mass use in malaria-endemic regions.
It is also thermostable, as it remains effective for more than nine months at room temperature.
It functions as a transmission-blocking vaccine, thereby helping reduce the overall spread of malaria in communities.